Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q3 2017 · 10-Q
Revenue$0.00$0.00— vs Q3 2016 Net Income-$2.87M-$2.87MN/M vs Q3 2016 EPS Diluted-$0.02-$0.02N/M vs Q3 2016 Operating Income-$2,060,619N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Sep 30, 2017 · filed Oct 19, 2017 · 19 d after period end